Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen Edge Medical CoHKSE:02675 -2.93%11 PB Ratio is 11.24 as of Aug. 14, 2026, which is 28% below its 10-year median of 15.64. GuruFocus rates HKSE:02675 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 783 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 91.7% on this metric.
Shenzhen Edge Medical Co Ltd stock PB Ratio (=11.54) is close to 1-year low of 10.72.
The historical rank and industry rank for Shenzhen Edge Medical Co's PB Ratio or its related term are showing as below:
HKSE:02675'
s PB Ratio Range Over the Past 10 Years
Min: 10.72 Med: 15.64 Max: 20.54
Current: 11.22
During the past 3 years, Shenzhen Edge Medical Co's highest PB Ratio was 20.54. The lowest was 10.72. And the median was 15.64.
HKSE:02675's PB Ratio is ranked worse than 91.7% of 783
companies
in the Medical Devices & Instruments industry
Industry Median: 2.13
vs HKSE:02675: 11.22
During the past 12 months, Shenzhen Edge Medical Co's average Book Value Per Share Growth Rate was -1.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co PB Ratio Chart
Shenzhen Edge Medical Co Annual Data
Trend
Dec23
Dec24
Dec25
PB Ratio
0.00
0.00
0.00
Shenzhen Edge Medical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
PB Ratio
0.00
0.00
0.00
0.00
0.00
HKSE:02675 vs ABT, SYK, MDT: PB Ratio Comparison
For the Medical Devices subindustry, Shenzhen Edge Medical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Edge Medical Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shenzhen Edge Medical Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shenzhen Edge Medical Co (HKSE:02675) has a PB Ratio of 11.24 as of Aug. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shenzhen Edge Medical Co and its competitors. This is 28% below median its historical median of 15.64. Over the past decade, Shenzhen Edge Medical Co's PB Ratio has ranged from 10.72 to 20.54. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #718 out of 783 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is Shenzhen Edge Medical Co's PB Ratio too high?
Shenzhen Edge Medical Co's current PB Ratio of 11.24 is 28% below median its 10-year median of 15.64. Over the past 10 years, this metric has ranged from a low of 10.72 to a high of 20.54. The Medical Devices & Instruments industry median PB Ratio is 2.13. Shenzhen Edge Medical Co's value of 11.24 is 427.7% above this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #718 out of 783 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #718 out of 783 companies for PB Ratio. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median PB Ratio is 2.13. Shenzhen Edge Medical Co's value of 11.24 is 427.7% above this benchmark. Historically, Shenzhen Edge Medical Co's own PB Ratio has ranged from 10.72 to 20.54 over the past decade. While the company's 10-year median is 15.64 vs. the industry median of 2.13, Shenzhen Edge Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.13, based on 783 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current PB Ratio of 11.24 is 427.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current PB Ratio is 11.24, which is 28% below median its own 10-year median of 15.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (HKSE:02675) has a current PB Ratio of 11.24. The current PB Ratio is 11.24, which is 28% below median its 10-year median of 15.64 and 427.7% above the Medical Devices & Instruments industry median of 2.13. Shenzhen Edge Medical Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shenzhen Edge Medical Co (HKSE:02675), the current PB Ratio is 11.24 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
11GF Score
Get the complete analysis for HKSE:02675
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02675 has been successfully added to your 
